期刊
CANCER LETTERS
卷 330, 期 1, 页码 57-66出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2012.11.020
关键词
Breast cancer; High throughput proteomics; Circulating markers
类别
This study evaluated the plasmatic proteomic profile of breast cancer patients in the early (ED) and advanced (AD) stages, employing high-throughput proteomics. We identified 92 differentially expressed proteins in ED and 73 proteins in AD patients. Gelsolin, lumican, clusterin, SALL4 and PMS2, as well hTERT, TNF-alpha, and GRHL3 were chosen for further investigation. ED presented augmented expression of GRHL3 and reduced circulating TNF-alpha with high expression of GRHL3 in tumors. AD displayed high TNF-alpha, and a significant expression of PMS2 in tumors. These findings suggest processes enrolling stem cell division in ED, with TNF-alpha signaling and DNA mismatch repair in the advanced stage. (C) 2012 Published by Elsevier Ireland Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据